Terms: = Kidney tumors AND RNF43, DKFZp781H02126, 54894, Q68DV7, URCC, RNF124, MGC125630, FLJ20315, DKFZp781H0392 AND Prognosis
4 results:
1. Pan-cancer analysis identifies rnf43 as a prognostic, therapeutic and immunological biomarker.
Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
[TBL] [Abstract] [Full Text] [Related]
2. rnf43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma.
Zhu D; Zhang L; Shi X; Gao S; Yue C; Zhang L; Bai YU; Wang Q; Okada A; Yasui T; Wang C; Cui X; Zuo LI
Oncol Res; 2021; 29(3):159-174. PubMed ID: 37304674
[TBL] [Abstract] [Full Text] [Related]
3. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
4. Combining expression of rnf43 and infiltration level of CD163
Zhu D; Shi X; Tian Y; Li H; Tang B; Zhang Z; Zhang Z; Zuo L
Cancer Med; 2023 Feb; 12(4):3962-3971. PubMed ID: 36097369
[TBL] [Abstract] [Full Text] [Related]
